在人类免疫缺陷病毒 (HIV) 相关的未知来源的发烧的实证结核病治疗:一个基于案例的理由
Matthew Antonioli1, Samantha H Antonioli1, Gabriel M Aisenberg1
1Internal Medicine, University of Texas Health Science Center at Houston, Houston, USA.
Cureus
|August 12, 2025
概括
感染艾滋病毒 (PLHIV) 的人群中源不明的发烧 (FUO) 通常涉及结核病 (TB). 本综述审查了在诊断不确定时使用FUO对PLHIV的实证结核病治疗的证据.
科学领域:
- 传染性疾病 传染性疾病
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 感染艾滋病毒 (PLHIV) 的人群中源不明发烧 (FUO) 定义为长期发烧,尽管进行了广泛的评估.
- 结核病 (TB) 是PLHIV的一个重要关注点,提出了一个诊断挑战.
- 目前在PLHIV中FUO的诊断途径往往没有确定性.
研究的目的:
- 审查现有关于实证抗结核治疗在PLHIV与FUO中的使用证据.
- 为在资源有限的环境中或在诊断确定性具有挑战的情况下为临床决策提供指导.
主要方法:
- 用FUO在PLHIV中评估经验性结核病治疗的研究的文献综述.
- 影响启动实证抗结核治疗决定的因素分析,包括区域结核病流行率和诊断局限性.
主要成果:
- 支持PLHIV与FUO实证结核病治疗的证据是可变的,并且取决于背景.
- 区域结核病流行率和诊断能力显著影响经验治疗的有用性.
结论:
- 在PLHIV中使用FUO启动实证抗结核治疗的决定需要仔细考虑个体患者的因素和当地流行病学.
- 需要进一步的研究,以制定明确的指导方针,以实证结核病治疗在这个人群.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.9K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.4K
相关概念视频
Pulmonary Tuberculosis V
239
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis III
443
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
443
Pulmonary Tuberculosis II
346
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
346
Pneumonia IV: Management
447
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
447
